RenovoRx (RNXT)

• Market cap: $34.9M
• 1 day: -1.41%
• 5 days: -4.56%
• 1 month: 0.09%
• 3 months: -7.68%
• 6 months: -22.06%
• Year to date: 13.85%
• 1 year: -36.18%
• 5 years: -86.9%
• 10 years: -86.9%
• Sector: Healthcare
• Industry: Biotechnology

About: RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Employees: 10